479 related articles for article (PubMed ID: 7508830)
1. Role of serotonin in the pathophysiology of depression: focus on the serotonin transporter.
Owens MJ; Nemeroff CB
Clin Chem; 1994 Feb; 40(2):288-95. PubMed ID: 7508830
[TBL] [Abstract][Full Text] [Related]
2. Altered serotonin function in suicide. Evidence from platelet and neuroendocrine studies.
Pandey GN
Ann N Y Acad Sci; 1997 Dec; 836():182-200. PubMed ID: 9616799
[TBL] [Abstract][Full Text] [Related]
3. Platelet 5-hydroxytryptamine (5-HT) transporter and 5-HT2A receptor binding after chronic hypercorticosteronemia, (+/-)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane administration or neurotoxin-induced depletion of central nervous system 5-HT in the rat.
Owens MJ; Ballenger CA; Knight DL; Nemeroff CB
J Pharmacol Exp Ther; 1996 Sep; 278(3):1040-9. PubMed ID: 8819484
[TBL] [Abstract][Full Text] [Related]
4. Further studies on platelet serotonin transporter binding in depression.
Nemeroff CB; Knight DL; Franks J; Craighead WE; Krishnan KR
Am J Psychiatry; 1994 Nov; 151(11):1623-5. PubMed ID: 7943450
[TBL] [Abstract][Full Text] [Related]
5. Reduced brain serotonin transporter availability in major depression as measured by [123I]-2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane and single photon emission computed tomography.
Malison RT; Price LH; Berman R; van Dyck CH; Pelton GH; Carpenter L; Sanacora G; Owens MJ; Nemeroff CB; Rajeevan N; Baldwin RM; Seibyl JP; Innis RB; Charney DS
Biol Psychiatry; 1998 Dec; 44(11):1090-8. PubMed ID: 9836013
[TBL] [Abstract][Full Text] [Related]
6. Lower 3H-paroxetine binding in cerebral cortex of suicide victims is partly due to fewer high affinity, non-transporter sites.
Mann JJ; Henteleff RA; Lagattuta TF; Perper JA; Li S; Arango V
J Neural Transm (Vienna); 1996; 103(11):1337-50. PubMed ID: 9013420
[TBL] [Abstract][Full Text] [Related]
7. Monoamine dysfunction and the pathophysiology and treatment of depression.
Charney DS
J Clin Psychiatry; 1998; 59 Suppl 14():11-4. PubMed ID: 9818625
[TBL] [Abstract][Full Text] [Related]
8. Binding of [3H]paroxetine to platelets of depressed patients: seasonal differences and effects of diagnostic classification.
D'Hondt P; Maes M; Leysen JE; Gommeren W; Scharpé S; Cosyns P
J Affect Disord; 1994 Sep; 32(1):27-35. PubMed ID: 7798464
[TBL] [Abstract][Full Text] [Related]
9. Neurochemical alterations of serotonergic neuronal systems in depression.
Risch SC; Nemeroff CB
J Clin Psychiatry; 1992 Oct; 53 Suppl():3-7. PubMed ID: 1331029
[TBL] [Abstract][Full Text] [Related]
10. Serotonergic dysfunction in depression.
Meltzer H
Br J Psychiatry Suppl; 1989 Dec; (8):25-31. PubMed ID: 2692637
[TBL] [Abstract][Full Text] [Related]
11. Serotonergic genes and suicidality.
Du L; Faludi G; Palkovits M; Bakish D; Hrdina PD
Crisis; 2001; 22(2):54-60. PubMed ID: 11727894
[TBL] [Abstract][Full Text] [Related]
12. Biochemical effects of antidepressant treatment--studies of monoamine metabolites in cerebrospinal fluid and platelet [3H]imipramine binding.
Asberg M; Wägner A
Ciba Found Symp; 1986; 123():57-83. PubMed ID: 2434288
[TBL] [Abstract][Full Text] [Related]
13. Serotonin 1A receptors, serotonin transporter binding and serotonin transporter mRNA expression in the brainstem of depressed suicide victims.
Arango V; Underwood MD; Boldrini M; Tamir H; Kassir SA; Hsiung S; Chen JJ; Mann JJ
Neuropsychopharmacology; 2001 Dec; 25(6):892-903. PubMed ID: 11750182
[TBL] [Abstract][Full Text] [Related]
14. Platelet serotonergic indices in major depression: up-regulation of 5-HT2A receptors unchanged by antidepressant treatment.
Hrdina PD; Bakish D; Ravindran A; Chudzik J; Cavazzoni P; Lapierre YD
Psychiatry Res; 1997 Feb; 66(2-3):73-85. PubMed ID: 9075272
[TBL] [Abstract][Full Text] [Related]
15. Binding of some antidepressants to the 5-hydroxytryptamine transporter in brain and platelets.
Marcusson JO; Ross SB
Psychopharmacology (Berl); 1990; 102(2):145-55. PubMed ID: 2274599
[TBL] [Abstract][Full Text] [Related]
16. Comparison of [3H]paroxetine and [3H]cyanoimipramine for quantitative measurement of serotonin transporter sites in human brain.
Gurevich EV; Joyce JN
Neuropsychopharmacology; 1996 May; 14(5):309-23. PubMed ID: 8703300
[TBL] [Abstract][Full Text] [Related]
17. Decreased platelet 3H-paroxetine binding in obsessive-compulsive patients.
Marazziti D; Rossi A; Gemignani A; Giannaccini G; Pfanner C; Milanfranchi A; Presta S; Lucacchini A; Cassano GB
Neuropsychobiology; 1996; 34(4):184-7. PubMed ID: 9121618
[TBL] [Abstract][Full Text] [Related]
18. Stress and antidepressant effects on hippocampal and cortical 5-HT1A and 5-HT2 receptors and transport sites for serotonin.
Watanabe Y; Sakai RR; McEwen BS; Mendelson S
Brain Res; 1993 Jun; 615(1):87-94. PubMed ID: 8364729
[TBL] [Abstract][Full Text] [Related]
19. Serotonergic hyperinnervation of the frontal cortex in an animal model of depression, the bulbectomized rat.
Zhou D; Grecksch G; Becker A; Frank C; Pilz J; Huether G
J Neurosci Res; 1998 Oct; 54(1):109-16. PubMed ID: 9778154
[TBL] [Abstract][Full Text] [Related]
20. The serotonergic antidepressant nefazodone inhibits the serotonin transporter: in vivo and ex vivo studies.
Owens MJ; Ieni JR; Knight DL; Winders K; Nemeroff CB
Life Sci; 1995; 57(24):PL373-80. PubMed ID: 7475971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
